Regeneron Pharmaceuticals reported $3B in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amgen AMGN:US $ 5097M 208M
Astellas Pharma 4503:JP Y 263018M 894M
AstraZeneca AZN:LN 6.04B 15M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Bristol Myers Squibb BMY:US $ 9333M 81M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Johnson & Johnson JNJ:US $ 16088M 343M
Kyowa Hakko Kirin 4151:JP Y 66088M 1038M
Merk MRK:US $ 10098M 1738M
Moderna Inc MRNA:US 4.25B 643M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Novartis NVS:US $ 9519M 21M
Pfizer PFE:US $ 14163M 2178M
Puma Biotechnology PBYI:US $ 35.97M 5.45M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
United Therapeutics UTHR:US $ 417M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M